2021 Fiscal Year Final Research Report
System Establishment to Collect Patient-Reported Outcomes from Breast Cancer Patients using the LINE Application and Feasibility Study
Project/Area Number |
19K09082
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 55010:General surgery and pediatric surgery-related
|
Research Institution | Keio University |
Principal Investigator |
SEKI Tomoko 慶應義塾大学, 医学部(信濃町), 助教 (70528900)
|
Co-Investigator(Kenkyū-buntansha) |
高橋 麻衣子 慶應義塾大学, 医学部(信濃町), 助教 (50348661)
林田 哲 慶應義塾大学, 医学部(信濃町), 講師 (80327543)
|
Project Period (FY) |
2019-04-01 – 2022-03-31
|
Keywords | PROs / ePROs / 乳癌 |
Outline of Final Research Achievements |
Patient-reported outcomes (PROs) in oncology is essential for assessing patient symptoms. A feasibility study was conducted on breast cancer patients by building a PRO data collection system based on LINE, one of the most popular social network service application in Japan. Seventy-three patients were enrolled. The median observation period was 435 days, and the total number of PROs collected was 16,417, with a mean of 224.9 reports per patient. Analyzing the results by age group, the number of responses from those aged 60 and above was equal to or higher than that of the younger age group. These results suggested that the design of the system, based on an application used daily, instead of using specifically prepared applications for collecting ePROs, was the reason for the favorable acceptance from patients and the satisfactory response rate from all age groups, including the elderly.
|
Free Research Field |
乳腺診療
|
Academic Significance and Societal Importance of the Research Achievements |
本研究の結果、LINEを用いたePROsの取得システムの使用により幅広い年齢層の乳がん患者から毎日の副作用に関する情報を収集することが可能であることが明らかとなり、今後、抗がん剤による重篤な副作用を未然に把握するなど、より安全・安心な新しい形の医療を提供できる可能性が考えられた。また本システムでは60歳を超える患者も良好な利用・継続が可能であり、日常的に使用するツールを基盤としてシステム構築を行うことで、PROs収集における良好なコンプライアンスが得られることが判明した。
|